Mettler-Toledo International Inc (MTD) fair value: what the stock is really worth
As of Nov 5, 2026: fair value (intrinsic value) of Mettler-Toledo International Inc stock $648, price $1,679, that is 61.4% below the price, quality 81 out of 100. Rating: strongly overvalued. Calculated from audited financials with 20 of our 26 valuation models and 37 quality factors, updated daily.
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 1, 2026.
How to read this chart
60‑month range $962.37 – $1,723 · fair‑value band $399.14 – $962.98 · the $1,679 price screens above the $648.30 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 1, 2026.
Follow Mettler-Toledo International in your weekly email
Every Wednesday you see whether Mettler-Toledo International is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations.
Show moreShow less
The company offers laboratory instruments, such as laboratory balances, liquid pipetting solutions, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, density and refractometry instruments, and thermal analysis systems; and other analytical instruments, including UV/VIS spectrophotometers, moisture analyzers, and cell counters, as well as LabX, a laboratory software platform to manage and analyze data generated by its instruments and automate workflows.
It also provides industrial instruments comprising industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detectors, x-ray systems, checkweighers, and camera-based imaging equipment.
In addition, the company offers retail weighing solutions consisting of weighing and software solutions, AI-driven image recognition solutions for fresh goods, and automated packaging and labeling solutions for the meat backroom.
The company serves pharmaceutical and biotech companies, independent research organizations, and testing labs; food manufacturers and retailers; chemical, specialty chemicals, and cosmetics companies; transportation and logistics, metals, and electronics industries; and academic community through its direct sales force and indirect distribution channels.
Mettler-Toledo International Inc. was incorporated in 1991 and is headquartered in Greifensee, Switzerland.
Stock analysis
Mettler-Toledo International Inc (MTD) currently trades at $1,679, while our model-based Fair Value estimate is $648.30, 61% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of $797.56 per share, and 0 of the 20 models we run sit above the $1,679 price.
Bear case: the Earnings-Based group reads lowest at $384.06, and 20 of the 20 models stay below the price. Data coverage for this calculation is medium.
Scenario range: $399.14 (bear) to $962.98 (bull), the price of $1,679 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 81/100 (high quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Mettler-Toledo International Inc reported revenue of $4.0B in FY2025 versus $3.7B in FY2021, a compound +2.0%/yr. Reported net income was $869M in FY2025, compounding +3.1%/yr from FY2021.
Key figures
Market cap $33.9B Large · P/E ratio 37.8 · P/S ratio 8.19 · EPS (TTM) $44.37 · Net margin 21.9% · Return on equity 29.5% · Return on assets (EBIT) 32.3% · Operating margin 31.2%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 88 out of 100 (low confidence).
What moves the price
The share trades about 3% below its 52-week high and 64% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −8% fair-value upside, at −61%, MTD screens richer than that median.
Fair Value models
Bear$399.14Fair Value $648.30Bull$962.98
Price $1,679 · Downside -61.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then ($37.68 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
In the last 6 months, 4 officers or directors sold shares worth $6.1M and none bought.
SalePatrick KaltenbachPresident and CEO2× since Nov 12, 2025: 2,942 shares, avg. $1,450$4.3MAug 27, 2026
SaleThomas P SaliceDirector2× since Aug 3, 2026: 832 shares, avg. $1,443$1.2MAug 5, 2026
SaleShawn VadalaChief Financial Officer4× since Nov 11, 2025: 6,960 shares, avg. $1,450$10.1MAug 3, 2026
SaleGerry KellerHead of Process Analytics2× since Nov 21, 2025: 476 shares, avg. $1,423$677,298Aug 3, 2026
SaleMarc de la GuerroniereHead of Eur & NA Market Orgs2× since Nov 11, 2025: 12,935 shares, avg. $1,468$19.0MNov 25, 2025
SaleElisha W FinneyDirector474 shares at $1,434$679,512Nov 10, 2025
Plus 12 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.80/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+4.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.5%
Start year 2020 (pandemic). Over 10 years: +5.3% a year
Revenue growth 28 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.6%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+11.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year+11.1%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.11.1% vs 12.9%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.25% → 28%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+23.6%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+4.5%
Yearly sales growth analysts expect, extended to five years.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +20.7% a year for the price and +2.0% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (96 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Positive
Recent news coverage is more positive than average.
AI conclusion: The business shows strength in precision instruments and software that support AI-driven pharma lab automation and data pooling, yet remains limited by thin evidence on operations, mixed profitability signals and negative total equity as a core weakness.
Main risk: Named competitors such as Sartorius in balances and lab systems or low-cost manufacturers from China and India could capture customers in entry-level or mid-market segments and force price or margin pressure on precision instruments and titrators.
Bull case: By deepening its direct sales and service network plus embedding AI features into existing instruments the company could strengthen customer lock-in and defend or expand share against rivals while securing alternative suppliers.
Bear case: If rivals gain traction with cheaper or broader offerings and key supplier issues persist the company could lose share in price-sensitive segments and face production constraints that erode its installed base advantage.
Mettler-Toledo makes precision instruments and software that help pharma labs automate experiments and pool data for AI analysis. Recent commentary highlights how rising AI-driven R&D productivity plus stronger China demand could lift utilization of its lab automation and analytical tools. Our models see the stock as overvalued, so does the AI opportunity bring enough extra growth to close the gap or has most of that potential already been priced in?
Compare Mettler-Toledo International Inc with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Diagnostics & Research · 126 stocks
Beats the industry median on 4/11 measures
Overall it trails its industry peers.
Valuation
Quality Score81 · Top 25%
Fair Value upside−61.4% · Below median
Profitability
Return on equity (12 months)Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets23.4% · Top 25%
Net margin (12 months)21.9% · Top 25%
Operating margin (12 months)31.2% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)4.5% · Below median
Balance sheet
Debt / equityNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Valuation Multiplesvs Diagnostics & Research median · lower = cheaper
P/E (12 months)37.8× · Pricier than median
P/BNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (12 months)8.19× · Priciest 25%
Price / free cash flow39.9× · Pricier than median
EV/EBITDA28.1× · Pricier than median
PEG2.77× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)23· sector 38
PAST (return on equity)0· sector 15
HEALTH (low debt)0· sector 95
DIVIDEND (yield)0· sector 32
VALUE 0: the price sits above our fair-value range.
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Mettler-Toledo International Inc Fair Value". https://www.fairvalue-calculator.com/stock/MTD
Frequently asked questions
Is Mettler-Toledo International Inc (MTD) overvalued or undervalued?
As of Nov 1, 2026, our model estimates a fair value of $648.30 versus a price of $1,679, about 61% lower (overvalued).
What is the fair value of MTD?
Our model-based fair value for Mettler-Toledo International Inc is $648.30 (as of Nov 1, 2026), built from audited fundamentals. The current price: $1,679.
What is the quality score of MTD?
Mettler-Toledo International Inc has a Quality Score of 81/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Mettler-Toledo International Inc (MTD)?
Our model-based price target is the fair value of $648.30 (as of Nov 1, 2026) from 20 valuation models. Cautious scenario $399.14, optimistic scenario $962.98. It is a calculation from audited fundamentals, not an analyst target.
What is the Mettler-Toledo International Inc stock forecast for 2026?
Our models put fair value at $648.30, about 61% lower versus a price of $1,679 (overvalued). Cautious scenario $399.14, optimistic scenario $962.98. The calculation is refreshed regularly with new filings.
What is the revenue of Mettler-Toledo International Inc (MTD)?
Mettler-Toledo International Inc reported trailing-twelve-month revenue of about $4.1B (latest available figure, as of Nov 1, 2026).
What growth is priced into Mettler-Toledo International Inc (MTD)?
For today's price to be fair in a discounted-cash-flow model, Mettler-Toledo International Inc would have to grow free cash flow by +23.6 % per year for five years (discount rate 9.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +5.5 % per year. As of Nov 1, 2026.
What discount rate (WACC) does the fair value of MTD use?
Our models discount Mettler-Toledo International Inc at 9.7 %: a base by market capitalisation (large), damped by beta 1.19, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Mettler-Toledo International Inc that is +23.6 % per year a year over ten years, using the same discount rate (9.7 %) and the same formula as our fair value.
How much growth has Mettler-Toledo International Inc (MTD) delivered so far?
Over the past 5 years revenue at Mettler-Toledo International Inc grew +5.5 % a year. The price currently implies +23.6 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Mettler-Toledo International Inc (MTD) growing?
The median revenue growth in the sector is +6.2 % a year. That is the yardstick for the growth priced into Mettler-Toledo International Inc (+23.6 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Mettler-Toledo International Inc (MTD)?
The free-cash-flow yield on the price is 2.51 %: that much free cash flow Mettler-Toledo International Inc produces per unit of market value. When it exceeds the discount rate of our models (9.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Mettler-Toledo International Inc (MTD)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Mettler-Toledo International Inc it is $648.30 per share (as of Nov 1, 2026), against a price of $1,679. It is the blended result of 20 valuation models (cash flow, earnings, asset, dividend).
Is Mettler-Toledo International Inc stock overvalued or undervalued in 2026?
As of Nov 1, 2026, MTD trades above its calculated fair value: price $1,679, fair value $648.30, a gap of about −61% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of MTD?
No. The price is what the market pays today ($1,679); the fair value is what the company's own numbers justify ($648.30). For Mettler-Toledo International Inc the two are $1,031 per share apart. That gap is exactly why we show both numbers side by side.
How much is Mettler-Toledo International Inc worth?
The market values Mettler-Toledo International Inc at about $33.9B (market capitalisation, as of Nov 1, 2026). Per share that is $1,679; our models calculate a fair value of $648.30 per share.
What do the bullish and bearish scenarios say about MTD?
Our models span a range for Mettler-Toledo International Inc: cautious scenario $399.14, base $648.30, optimistic $962.98 per share (as of Nov 1, 2026, price $1,679). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of MTD?
Mettler-Toledo International Inc trades at a price-to-earnings ratio of 37.8 (as of Nov 1, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $648.30 is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings, 5 of the years ex one-offs: 33.6. Other multiples: PEG 2.8, P/S 8.2, EV/EBITDA 28.1.
What is the PEG ratio of MTD?
The PEG ratio of Mettler-Toledo International Inc is 2.77 (P/E divided by earnings growth, as of Nov 1, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Mettler-Toledo International Inc (MTD)?
Balance-sheet figures for Mettler-Toledo International Inc (as of Nov 1, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 81/100, which measures business quality independently of the share price.
How far is MTD from its 52-week high?
Mettler-Toledo International Inc trades at $1,679, about 3% below its 52-week high of $1,723 and 64% above the low of $1,026 (as of Nov 5, 2026). Distance from the high says nothing about value: that is what the fair value of $648.30 is for.
Which stocks are comparable to Mettler-Toledo International Inc?
From the same area (Healthcare) we also value Thermo Fisher Scientific Inc, Danaher Corporation, WuXi AppTec Co, Lonza Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Mettler-Toledo International Inc stock attractive at the current price?
The data as of Nov 1, 2026: price $1,679, calculated fair value $648.30 (−61%), Quality Score 81/100, from 20 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of MTD calculated?
We run Mettler-Toledo International Inc through 20 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $648.30, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.5% above its aggregate fair value. Mettler-Toledo International Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Mettler-Toledo International Inc (MTD)?
The closing price on Nov 5, 2026 was $1,679. Our model-based fair value is $648.30, about 61% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Mettler-Toledo International Inc right now?
A high-quality business (quality 81/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety. The price sits above even our optimistic bull case ($962.98). The favourable scenario is already priced in. A fairly wide model range ($399.14 to $962.98) leaves room in how you read the outcome.
Where does the earnings growth of Mettler-Toledo International Inc (MTD) come from?
Earnings per share at Mettler-Toledo International Inc grew +13.4 % a year from 2014 to 2025. Broken into its drivers: revenue per share +8.6 %, EBIT margin +3.8 %, tax rate +0.9 %, residual (interest, one-offs) −0.3 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Mettler-Toledo International Inc
How large is the market capitalisation of Mettler-Toledo International Inc (MTD)?
The market capitalisation of Mettler-Toledo International Inc is $33.9B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Mettler-Toledo International Inc (MTD)?
The price-to-sales ratio of Mettler-Toledo International Inc is 8.19 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Mettler-Toledo International Inc (MTD)?
Earnings per share at Mettler-Toledo International Inc are $44.37 (price ÷ EPS = P/E 37.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Mettler-Toledo International Inc (MTD)?
The net margin of Mettler-Toledo International Inc is 21.9% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Mettler-Toledo International Inc (MTD)?
The return on equity (ROE) of Mettler-Toledo International Inc is 29.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Mettler-Toledo International Inc (MTD)?
On an EBIT basis the return on assets of Mettler-Toledo International Inc is 32.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Mettler-Toledo International Inc (MTD)?
The operating margin of Mettler-Toledo International Inc is 31.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Mettler-Toledo International Inc (MTD)?
Revenue at Mettler-Toledo International Inc is growing +4.5% versus a year earlier (3y avg +0.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Mettler-Toledo International Inc (MTD)?
Earnings per share at Mettler-Toledo International Inc are growing +18.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Mettler-Toledo International Inc (MTD) carry?
The net debt of Mettler-Toledo International Inc is $2.3B (fiscal year 2025, ≈ 2.7 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Mettler-Toledo International Inc in the live analysis
One click puts Mettler-Toledo International Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 1, 2026